New York: Federal Minister for Finance and Revenue, Senator Muhammad Aurangzeb, has called for a more rapid implementation of Pakistan’s Hepatitis C elimination programme. This appeal was made during a meeting with a representative of Abbott’s Pharmaceuticals Division, coinciding with his visit to the 81st Session of the United Nations General Assembly (UNGA). The conversation also expanded to cover broader issues within the pharmaceutical sector.

According to Press Information Department, the Finance Minister expressed his apprehensions over the slow advancement of the programme, highlighting that only around 100,000 out of the three million procured diagnostic tests had been used. He attributed this lag to leadership turnover, poor project management, and limited public awareness.

During the meeting, the Finance Minister acknowledged Abbott’s technical support, informed by its experience with Egypt’s extensive screening initiative. Discussions also touched on enhancements in the Drug Regulatory Authority of Pakistan’s (DRAP) regulatory capabilities, diversification of pharmaceutical exports, Abbott’s oncology treatment plans, and delays in resolving hardship medicine-pricing cases.

Senator Aurangzeb emphasized the importance of achieving a balance between affordability and commercial viability, while ensuring a steady supply. He committed to addressing the programme’s implementation issues with the relevant authorities in Pakistan to facilitate swifter progress.